| INTRODUCTION
The field of radiotherapy (RT) has benefited substantially from advancements in Image-Guided Radiotherapy (IGRT) in the past 15 years. IGRT now constitutes the integration of a wide range of imaging technology with modern RT delivery systems that include 3D anatomical and functional-based imaging for tumor volume identification, 3D target volume localization, and motion management information for precise patient setup and monitoring. 1, 2 To streamline this complex process, system integration of planning and delivery with multimodality IGRT technologies is now a primary selling point for vendors. This integration becomes more complex with the increased number of image-guided patient positioning and motion management options. Current IGRT technologies include not only various x-ray based imaging systems but also other modalities, such as video/infrared (IR) cameras, ultrasound (US), and electromagnetic field systems. The capital purchase decision makers at hospitals welcome tools that allow for improved image guidance when it is consistent with their strategies for return on investment. But this may raise multiple issues that need to be addressed by medical physicists, including safe and practical implementation and commissioning, personnel qualification and training of staff, updates and servicing to ensure integration between systems, and of course reimbursement constraints. This brings us to our debate topic: Will more IGRT systems implemented in the clinic lead to better outcomes for RT treatments?
Arguing for the proposition is Dr. Baozhou Sun. Dr. Sun is an assistant professor and chief of quality assurance services of radia- The goal of RT is to deliver high dose to the tumor while sparing adjacent normal healthy tissues. The geometric accuracy of dose deposited to the desired target is critical to ensure high quality of treatments. IGRT has been introduced to reduce geometric uncertainties in RT. The diverse technologies of IGRT have been proved to be an effective quality control process that reduces the systematic and random uncertainties in the treatment process. 3 In the era of precision and personalized medicine, more IGRT technologies should be developed and implemented to provide more benefits to patient care. The Overall, the use of IGRT in improving treatment margin reduction, hypofractionated RT accuracy, and adaptive RT will ultimately improve clinical outcomes. 4, 5 It is without questions that IGRT is critical for ensuring treat- 1. 2D planar imaging using MV EPID and kV on-board imager (OBI).
Both EPID and kV OBI imaging systems are standard IGRT equipment for almost all linacs. These images are lack of soft tissue contrast, but provide bony landmarks as an aligning surrogate.
The 2D kV with fiducials can also be used for tumor tracking for robotic radiosurgery system.
3D volumetric imaging technology (CBCT, MV helical CT, and inroom helical CT). CBCT provides better contrast resolution than
MV helical CT (e.g., tomotherapy) and is the most commonly used system for daily localization on modern linacs. Image quality of MV CT is inferior compared to kV CT, but MV CT can reduce metal artifacts, which is useful for patients with dental filling or prosthesis. In-room CT or CT-on-rails has been developed for IGRT. However, it has not been adopted by many due to its bulky size, high cost, and impracticality to implement in a regular linac room. Recently, a more compact design of mobile CTs has emerged and implemented for proton therapy. 6 CT-on-rails or mobile CTs can also be used with brachytherapy high-dose rate (HDR) after-loaders for image guidance brachytherapy. 7 Nevertheless, the 3D volumetric imaging does not provide "snap shot" information and cannot be used for intra-fraction monitoring or correction. With the advantages of no extra radiation to patients, the nonradiation-based systems have also been widely implemented in RT, which include:
1. Camera-based systems (e.g., surface monitor systems such as
VisionRT or C-Rad). These systems can be used for patient positioning and intra-fraction monitoring. Yet they are mostly limited to situations where external surface acts as a reliable surrogate for internal position or motion.
2. Electromagnetic tracking (e.g., Calypso). This system uses electromagnetic transponders embedded within the tumor, and motion of these transponders may be tracked in real time using a detector array system. However, it is only limited to prostate. Finally, technology is the most significant contributing factor to the growth in healthcare spending, and it is essential to attain good value for money spent in technology development. 17 The "substantially accelerated" pace in developing more complex IGRT technologies needs to take a breath. Instead, more efforts should be spent on developing IGRT systems that are simpler, more robust, and less expensive but can still provide good values. Until then, the statement "more IGRT systems implemented in clinic are better for radiotherapy outcomes" is only true in theory but not in practice.
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